Memorial Sloan Kettering Cancer Center Seeks Scientist for Sarcoma Research Lab

Health ニュース

Memorial Sloan Kettering Cancer Center Seeks Scientist for Sarcoma Research Lab
Memorial Sloan Kettering Cancer CenterMSKCancer
  • 📰 Nature
  • ⏱ Reading Time:
  • 51 sec. here
  • 13 min. at publisher
  • 📊 Quality Score:
  • News: 62%
  • Publisher: 68%

Memorial Sloan Kettering Cancer Center (MSK) is looking for an experienced Scientist to join Dr. Singer’s Sarcoma Research Lab. The lab is dedicated to gene target identification and drug discovery in soft tissue sarcoma through a genome-wide genetic and functional analysis. The goal is to elucidate the mutational programs and pathways involved in sarcomagenesis and identify novel therapeutic targets.

Memorial Sloan Kettering Cancer Center ( MSK ) is one of the world’s premier cancer centers, committed to exceptional patient care, leading-edge research, and superb educational programs. The blending of research with patient care is at the heart of everything we do.

The institution is a comprehensive cancer center whose purposes are the treatment and control of cancer, the advancement of biomedical knowledge through laboratory and clinical research, and the training of scientists, physicians and other health care workers. Dr. Singer’s Sarcoma Research Lab is seeking an experienced Scientist to join their NIH funded laboratory dedicated to gene target identification and drug discovery in soft tissue sarcoma through a genome-wide genetic and functional analysis. The overall goal of the lab is to perform a comprehensive molecular genetic and functional analysis of soft tissue sarcoma, so as to elucidate the mutational programs and pathways involved in sarcomagenesis and to identify novel therapeutic targets. Sarcoma tissue samples and cell lines are subjected to a multiplatform genome-wide characterization of expression of protein-coding genes and microRNAs, DNA copy number changes, activating mutations, gene rearrangements and methylation profilin

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

Nature /  🏆 64. in US

Memorial Sloan Kettering Cancer Center MSK Cancer Research Sarcoma Gene Target Identification Drug Discovery Genetic Analysis Functional Analysis Mutational Programs Therapeutic Targets

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Cycle for Survival raising money to beat rare and pediatric cancersCycle for Survival raising money to beat rare and pediatric cancersAll of the money raised goes to rare cancer research at Memorial Sloan Kettering Cancer Center.
続きを読む »

2 giant inflatable colons help Intermountain Health cancer experts raise colon cancer awareness2 giant inflatable colons help Intermountain Health cancer experts raise colon cancer awarenessIntermountain Health cancer experts are doubling their efforts to raise awareness about colorectal cancer this month.
続きを読む »

Colon cancer: Phoenix area woman shares her battle during Colorectal Cancer Awareness MonthColon cancer: Phoenix area woman shares her battle during Colorectal Cancer Awareness MonthMarch is Colorectal Cancer Awareness Month, and a Phoenix area woman is telling the story of her battle with the disease, and advice she has for others.
続きを読む »

Jemperli Cancer Drug: What To Know As GSK Says It Improves Survival For Uterine Cancer PatientsJemperli Cancer Drug: What To Know As GSK Says It Improves Survival For Uterine Cancer PatientsI cover breaking news for Forbes. Before Forbes, I worked as a reporter for USA Today in Asheville and Black Mountain, North Carolina. I received my bachelor's degree in journalism from Auburn University and my master's degree in journalism from Northwestern University.
続きを読む »

Actress Olivia Munn's Breast Cancer Diagnosis Prompts Increased Use of Cancer Risk Assessment ToolActress Olivia Munn's Breast Cancer Diagnosis Prompts Increased Use of Cancer Risk Assessment ToolWhen Olivia Munn revealed this week that she was diagnosed with breast cancer, she urged people to ask their doctors to figure out their score on a breast…
続きを読む »

American Cancer Society finds 'homophobia' and 'discrimination' can 'increase cancer risk' in LGBTQ+ peopleAmerican Cancer Society finds 'homophobia' and 'discrimination' can 'increase cancer risk' in LGBTQ+ peopleLeading cancer research organization, American Cancer Society, published a first-of-its-kind report outlining how LGBTQ+ individuals are more susceptible to an increased risk of cancer.
続きを読む »



Render Time: 2025-03-13 13:58:44